Roles of hydrogen sulfide in the pathogenesis of diabetes mellitus and its complications

Antioxidants and Redox Signaling

Volumn 17, Issue 1, 2012, Pages 68-80

  Szabo, Csaba ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIACYLGLYCEROL; GARLIC EXTRACT; GLUCAGON; GLUCOSE; GLUTATHIONE; HYDROGEN SULFIDE; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; VASCULOTROPIN; XANTHINE OXIDASE;

ADIPOCYTE; ANGIOGENESIS; AUTOIMMUNITY; CARDIOVASCULAR FUNCTION; CELL DEATH; CELL MEMBRANE; CELL METABOLISM; CELL MIGRATION; CELL PROLIFERATION; CONGESTIVE CARDIOMYOPATHY; DIABETES MELLITUS; DIABETIC CARDIOMYOPATHY; DIABETIC FOOT; DIABETIC NEPHROPATHY; ENDOPLASMIC RETICULUM; ENDOTHELIUM INJURY; GLUCAGON RELEASE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HOMEOSTASIS; HUMAN; HYPERGLYCEMIA; HYPOINSULINEMIA; INHIBITION KINETICS; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; LEUKOCYTE ADHERENCE; METABOLIC SYNDROME X; MITOCHONDRIAL RESPIRATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION; WOUND HEALING;

ANIMALS; DIABETES COMPLICATIONS; DIABETES MELLITUS; HUMANS; HYDROGEN SULFIDE;

EID: 84860736030     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2011.4451     Document Type: Review

References (80)

1. Ali MY, Whiteman M, Low CM, and Moore PK. Hydrogen sulphide reduces insulin secretion from HIT-T15 cells by a KATP channel-dependent pathway. J Endocrinol 195: 105-112, 2007.
2. Baluchnejadmojarad T and Roghani M. Endotheliumdependent and-independent effect of aqueous extract of garlic on vascular reactivity on diabetic rats. Fitoterapia 74: 630-637, 2003.
3. Baskar R, Li L, and Moore PK. Hydrogen sulfide-induces DNA damage and changes in apoptotic gene expression in human lung fibroblast cells. FASEB J 21: 247-255, 2007.
4. Benavides GA, Squadrito GL, Mills RW, Patel HD, Isbell TS, Patel RP, Darley-Usmar VM, Doeller JE, and Kraus DW. Hydrogen sulfide mediates the vasoactivity of garlic. Proc Natl Acad Sci USA 104: 17977-17982, 2007.
5. Brancaleone V, Roviezzo F, Vellecco V, De Gruttola L, Bucci M, and Cirino G. Biosynthesis of H2S is impaired in non-obese diabetic (NOD) mice. Br J Pharmacol 155: 673-680, 2008.
6. Cai WJ, Wang MJ, Moore PK, Jin HM, Yao T, and Zhu YC. The novel proangiogenic effect of hydrogen sulfide is dependent on Akt phosphorylation. Cardiovasc Res 76: 29-40, 2007.
7. Caliendo G, Cirino G, Santagada V, and Wallace JL. Synthesis and biological effects of hydrogen sulfide (H2S): development of H2S-releasing drugs as pharmaceuticals. J Med Chem 53: 6275-6286, 2010.
8. Calvert JW, Coetzee WA, and Lefer DJ. Novel insights into hydrogen sulfide-mediated cytoprotection. Antioxid Redox Signal 12: 1203-1217, 2010.
9. Calvert JW, Jha S, Gundewar S, Elrod JW, Ramachandran A, Pattillo CB, Kevil CG, and Lefer DJ. Hydrogen sulfide mediates cardioprotection through Nrf2 signaling. Circ Res 105: 365-374, 2009.
10. Carballal S, Trujillo M, Cuevasanta E, Bartesaghi S, Möller MN, Folkes LK, Garća-Bereguián MA, Gutiérrez-Merino C, Wardman P, Denicola A, Radi R, and Alvarez B. Reactivity of hydrogen sulfide with peroxynitrite and other oxidants of biological interest. Free Radic Biol Med 50: 196-205, 2011.
11. Chang SH, Liu CJ, Kuo CH, Chen H, Lin WY, Teng KY, Chang SW, Tsai CH, Tsai FJ, Huang CY, Tzang BS, and Kuo WW. Garlic oil alleviates MAPKs-and IL-6-mediated diabetes-related cardiac hypertrophy in STZ-induced DM rats. Evid Based Complement Alternat Med 2011: 950150, 2011.
12. Chuah SC, Moore PK, and Zhu YZ. S-allylcysteine mediates cardioprotection in an acute myocardial infarction rat model via a hydrogen sulfide-mediated pathway. Am J Physiol Heart Circ Physiol 293: H2693-H2701, 2007.
13. Del Valle HF, Lascano EC, Negroni JA, and Crottogini AJ. Absence of ischemic preconditioning protection in diabetic sheep hearts: role of sarcolemmal KATP channel dysfunction. Mol Cell Biochem 249: 21-30, 2003.
14. Denizalti M, Bozkurt TE, Akpulat U, Sahin-Erdemli I, and Abacioglu N. The vasorelaxant effect of hydrogen sulfide is enhanced in streptozotocin-induced diabetic rats. Naunyn Schmiedebergs Arch Pharmacol 383: 509-517, 2011.
15. Di Filippo C, Cuzzocrea S, Rossi F, Marfella R, and D'Amico M. Oxidative stress as the leading cause of acute myocardial infarction in diabetics. Cardiovasc Drug Rev 24: 77-87, 2006.
16. Doeller JE, Isbell TS, Benavides G, Koenitzer J, Patel H, Patel RP, Lancaster JR Jr., Darley-Usmar VM, and Kraus DW. Polarographic measurement of hydrogen sulfide production and consumption by mammalian tissues. Anal Biochem 341: 40-51, 2005.
17. Eghbal MA, Pennefather PS, and O'Brien PJ. H2S cytotoxicity mechanism involves reactive oxygen species formation and mitochondrial depolarisation. Toxicology 203: 69-76, 2004.
18. Ejaz S, Chekarova I, Cho JW, Lee SY, Ashraf S, and Lim CW. Effect of aged garlic extract on wound healing: a new frontier in wound management. Drug Chem Toxicol 32: 191-203, 2009.
19. El-Seweidy MM, Sadik NA, and Shaker OG. Role of sulfurous mineral water and sodium hydrosulfide as potent inhibitors of fibrosis in the heart of diabetic rats. Arch Biochem Biophys 506: 48-57, 2011.
20. Elrod JW, Calvert JW, Morrison J, Doeller JE, Kraus DW, Tao L, Jiao X, Scalia R, Kiss L, Szabo C, Kimura H, Chow CW, and Lefer DJ. Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci USA 104: 15560-15565, 2007.
21. Elsey DJ, Fowkes RC, and Baxter GF. Regulation of cardiovascular cell function by hydrogen sulfide. Cell Biochem Funct 28: 95-106, 2010.
22. Feng X, Chen Y, Zhao J, Tang C, Jiang Z, and Geng B. Hydrogen sulfide from adipose tissue is a novel insulin resistance regulator. Biochem Biophys Res Commun 380: 153-159, 2009.
23. Ferdinandy P, Schulz R, and Baxter GF. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev 59: 418-458, 2007.
24. Francis RC, Vaporidi K, Bloch KD, Ichinose F, and Zapol WM. Protective and detrimental effects of sodium sulfide and hydrogen sulfide in murine ventilator-induced lung injury. Anesthesiology 115: 1012-1021, 2011.
25. Gao Y, Yao X, Zhang Y, Li W, Kang K, Sun L, and Sun X. The protective role of hydrogen sulfide in myocardial ischemia-reperfusion-induced injury in diabetic rats. Int J Cardiol 152: 177-183, 2011.
26. Garcia Soriano F, Virag L, Jagtap P, Szabo E, Mabley JG, Liaudet L, Marton A, Hoyt DG, Murthy KG, Salzman AL, Southan GJ, and Szabo C. Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation. Nat Med 7: 108-113, 2001.
27. Giacco F and Brownlee M. Oxidative stress and diabetic complications. Circ Res 107: 1058-1070, 2010.
28. Goubern M, Andriamihaja M, Nübel T, Blachier F, and Bouillaud F. Sulfide, the first inorganic substrate for human cells. FASEB J 21: 1699-1706, 2007.
29. Guan Q, Zhang Y, Yu C, Liu Y, Gao L, and Zhao J. Hydrogen sulfide protects against high glucose-induced apoptosis in endothelial cells. J Cardiovasc Pharmacol 152: 177-183, 2011.
30. Haller MJ, Atkinson MA, and Schatz DA. Efforts to prevent and halt autoimmune b cell destruction. Endocrinol Metab Clin North Am 39: 527-539, 2010.
31. Hildebrandt TM. Modulation of sulfide oxidation and toxicity in rat mitochondria by dehydroascorbic acid. Biochim Biophys Acta 1807: 1206-1213, 2011.
32. Insko MA, Deckwerth TL, Hill P, Toombs CF, and Szabo C. Detection of exhaled hydrogen sulphide gas in rats exposed to intravenous sodium sulphide. Br J Pharmacol 157: 944-951, 2009.
33. Jain SK, Bull R, Rains JL, Bass PF, Levine SN, Reddy S, McVie R, and Bocchini JA. Low levels of hydrogen sulfide in the blood of diabetes patients and streptozotocin-treated rats causes vascular inflammation? Antioxid Redox Signal 12: 1333-1337, 2010.
34. Jeney V, Komódi E, Nagy E, Zarjou A, Vercellotti GM, Eaton JW, Balla G, and Balla J. Supression of hemin-mediated oxidation of low-density lipoprotein and subsequent endothelial reactions by hydrogen sulfide. Free Radic Biol Med 46: 616-623, 2009.
35. Jha S, Calvert JW, Duranski MR, Ramachandran A, and Lefer DJ. Hydrogen sulfide attenuates hepatic ischemiareperfusion injury: role of antioxidant and antiapoptotic signaling. Am J Physiol Heart Circ Physiol 295: H801-H806, 2008.
36. Ji Y, Pang QF, Xu G, Wang L, Wang JK, and Zeng YM. Exogenous hydrogen sulfide postconditioning protects isolated rat hearts against ischemia-reperfusion injury. Eur J Pharmacol 587: 1-7, 2008.
37. Johnson JD and Luciani DS. Mechanisms of pancreatic b-cell apoptosis in diabetes and its therapies. Adv Exp Med Biol 654: 447-462, 2010.
38. Kaminitz A, Stein J, Yaniv I, and Askenasy N. The vicious cycle of apoptotic b-cell death in type 1 diabetes. Immunol Cell Biol 85: 582-589, 2007.
39. Kaneko Y, Kimura T, Taniguchi S, Souma M, Kojima Y, Kimura Y, Kimura H, and Niki I. Glucose-induced production of hydrogen sulfide may protect the pancreatic b-cells from apoptotic cell death by high glucose. FEBS Lett 583: 377-382, 2009.
40. Kaneko Y, Kimura Y, Kimura H, and Niki I. L-cysteine inhibits insulin release from the pancreatic b-cell: possible involvement of metabolic production of hydrogen sulfide, a novel gasotransmitter. Diabetes 55: 1391-1397, 2006.
41. Kimura H. Hydrogen sulfide: its production, release and functions. Amino Acids 41: 113-121, 2011.
42. Lagoutte E, Mimoun S, Andriamihaja M, Chaumontet C, Blachier F, and Bouillaud F. Oxidation of hydrogen sulfide remains a priority in mammalian cells and causes reverse electron transfer in colonocytes. Biochim Biophys Acta 1797: 1500-1511, 2010.
43. Lan A, Liao X, Mo L, Yang C, Yang Z, Wang X, Hu F, Chen P, Feng J, Zheng D, and Xiao L. Hydrogen sulfide protects against chemical hypoxia-induced injury by inhibiting ROSactivated ERK1/2 and p38MAPK signaling pathways in PC12 cells. PLoS One 6: e25921, 2011.
44. Lavu M, Bhushan S, and Lefer DJ. Hydrogen sulfide-mediated cardioprotection: mechanisms and therapeutic potential. Clin Sci (Lond) 120: 219-229, 2011.
45. Lefer DJ. A new gaseous signaling molecule emerges: cardioprotective role of hydrogen sulfide. Proc Natl Acad Sci USA 104: 17907-17908, 2007.
46. Levitt MD, Abdel-Rehim MS, and Furne J. Free and acidlabile hydrogen sulfide concentrations in mouse tissues: anomalously high free hydrogen sulfide in aortic tissue. Antioxid Redox Signal 15: 373-378, 2011.
47. Martelli A, Testai L, Breschi MC, Blandizzi C, Virdis A, Taddei S, and Calderone V. Hydrogen sulphide: novel opportunity for drug discovery. Med Res Rev 2011 [Epub ahead of print]. PMID: 21140432.
48. Nicholls P. Inhibition of cytochrome c oxidase by sulphide. Biochem Soc Trans 3: 316-319, 1975.
49. Olson KR. Is hydrogen sulfide a circulating "gasotransmitter" in vertebrate blood? Biochim Biophys Acta 1787: 856-863, 2009.
50. Ou HC, Tzang BS, Chang MH, Liu CT, Liu HW, Lii CK, Bau DT, Chao PM, and Kuo WW. Cardiac contractile dysfunction and apoptosis in streptozotocin-induced diabetic rats are ameliorated by garlic oil supplementation. J Agric Food Chem 58: 10347-10355, 2010.
51. Pacher P, Liaudet L, Soriano FG, Mabley JG, Szabo E, and Szabo C. The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes. Diabetes 51: 514-521, 2002.
52. Pan TT, Chen YQ, and Bian JS. All in the timing: a comparison between the cardioprotection induced by H2S preconditioning and post-infarction treatment. Eur J Pharmacol 616: 160-165, 2009.
53. Papapetropoulos A, Pyriochou A, Altaany Z, Yang G, Marazioti A, Zhou Z, Jeschke MG, Branski LK, Herndon DN, Wang R, and Szabo C. Hydrogen sulfide is an endogenous stimulator of angiogenesis. Proc Natl Acad Sci USA 106: 21972-21977, 2009.
54. Patel M and Shah G. Possible role of hydrogen sulfide in insulin secretion and in development of insulin resistance. J Young Pharm 2: 148-151, 2010.
55. Shaik IH, George JM, Thekkumkara TJ, and Mehvar R. Protective effects of diallyl sulfide, a garlic constituent, on the warm hepatic ischemia-reperfusion injury in a rat model. Pharm Res 25: 2231-2242, 2008.
56. Shen X, Pattillo CB, Pardue S, Bir SC, Wang R, and Kevil CG. Measurement of plasma hydrogen sulfide in vivo and in vitro. Free Radic Biol Med 50: 1021-1031, 2011.
57. Sodha NR, Clements RT, Feng J, Liu Y, Bianchi C, Horvath EM, Szabo C, Stahl GL, and Sellke FW. Hydrogen sulfide therapy attenuates the inflammatory response in a porcine model of myocardial ischemia/reperfusion injury. J Thorac Cardiovasc Surg 138: 977-984, 2009.
58. Suzuki K, Olah G, Modis K, Coletta C, Kulp G, Gero D, Szoleczky P, Chang T, Zhou Z, Wu L, Wang R, Papapetropoulos A, and Szabo C. Hydrogen sulfide replacement therapy protects the vascular endothelium in hyperglycemia by preservingmitochondrial function. Proc Natl Acad Sci USA 108: 13829-13834, 2011.
59. Szabo C and Papapetropoulos A. Hydrogen sulfide and angiogenesis: mechanisms and applications. Br J Pharmacol 164: 853-865, 2011.
60. Szabo C. Gaseotransmitters: new frontiers for translational science. Sci Transl Med 2: 59ps54, 2010.
61. Szabo C. Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov 6: 917-935, 2007.
62. Szabo C. Role of nitrosative stress in the pathogenesis of diabetic vascular dysfunction. Br J Pharmacol 156: 713-727, 2009.
63. Szabo G, Veres G, Radovits T, Gero D, Modis K, Miesel-Gröschel C, Horkay F, Karck M, and Szabo C. Cardioprotective effects of hydrogen sulfide. Nitric Oxide 25: 201-210, 2011.
64. Taniguchi S, Kang L, Kimura T, and Niki I. Hydrogen sulphide protects mouse pancreatic b-cells from cell death induced by oxidative stress, but not by endoplasmic reticulum stress. Br J Pharmacol 162: 1171-1178, 2011.
65. Taniguchi S and Niki I. Significance of hydrogen sulfide production in the pancreatic beta-cell. J Pharmacol Sci 116: 1-5, 2011.
66. Thompson RW, Valentine HL, and Valentine WM. Cytotoxic mechanisms of hydrosulfide anion and cyanide anion in primary rat hepatocyte cultures. Toxicology 188: 149-159, 2003.
67. Toombs CF, Insko MA, Wintner EA, Deckwerth TL, Usansky H, Jamil K, Goldstein B, Cooreman M, and Szabo C. Detection of exhaled hydrogen sulphide gas in healthy human volunteers during intravenous administration of sodium sulphide. Br J Clin Pharmacol 69: 626-636, 2010.
68. Truong DH, Mihajlovic A, Gunness P, Hindmarsh W, and O'Brien PJ. Prevention of hydrogen sulfide-induced mouse lethality and cytotoxicity by hydroxocobalamin (vitamin B12a). Toxicology 242: 16-22, 2007.
69. van Belle TL, Coppieters KT, and von Herrath MG. Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiol Rev 91: 79-118, 2011.
70. Watson D and Loweth AC. Oxidative and nitrosative stress in b-cell apoptosis: their contribution to b-cell loss in type 1 diabetes mellitus. Br J Biomed Sci 66: 208-215, 2009.
71. Whiteman M, Gooding KM, Whatmore JL, Ball CI, Mawson D, Skinner K, Tooke JE, and Shore AC. Adiposity is a major determinant of plasma levels of the novel vasodilator hydrogen sulphide. Diabetologia 53: 1722-1726, 2010.
72. Wintner EA, Deckwerth TL, Langston W, Bengtsson A, Leviten D, Hill P, Insko MA, Dumpit R, VandenEkart E, Toombs CF, and Szabo C. A monobromobimane-based assay to measure the pharmacokinetic profile of reactive sulphide species in blood. Br J Pharmacol 160: 941-957, 2010.
73. Wu L, Yang W, Jia X, Yang G, Duridanova D, Cao K, and Wang R. Pancreatic islet overproduction of H2S and suppressed insulin release in Zucker diabetic rats. Lab Invest 89: 59-67, 2009.
74. Yang G, Tang G, Zhang L, Wu L, and Wang R. The pathogenic role of cystathionine c-lyase/hydrogen sulfide in streptozotocin-induced diabetes in mice. Am J Pathol 179: 869-879, 2011.
75. Yang G, Wu L, Jiang B, Yang W, Qi J, Cao K, Meng Q, Mustafa AK, Mu W, Zhang S, Snyder SH, and Wang R. H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science 322: 587-590, 2008.
76. Yang G, Yang W, Wu L, and Wang R. H2S, endoplasmic reticulum stress, and apoptosis of insulin-secreting b cells. J Biol Chem 282: 16567-16576, 2007.
77. Yang Z, Yang C, Xiao L, Liao X, Lan A, Wang X, Guo R, Chen P, Hu C, and Feng J. Novel insights into the role of HSP90 in cytoprotection of H2S against chemical hypoxiainduced injury in H9c2 cardiac myocytes. Int J Mol Med 28: 397-403, 2011.
78. Yuan P, Xue H, Zhou L, Qu L, Li C, Wang Z, Ni J, Yu C, Yao T, Huang Y, Wang R, and Lu L. Rescue of mesangial cells from high glucose-induced over-proliferation and extracellular matrix secretion by hydrogen sulfide. Nephrol Dial Transplant 26: 2119-2126, 2011.
79. Yusuf M, Kwong Huat BT, Hsu A, Whiteman M, Bhatia M, and Moore PK. Streptozotocin-induced diabetes in the rat is associated with enhanced tissue hydrogen sulfide biosynthesis. Biochem Biophys Res Commun 333: 1146-1152, 2005.
80. Zhang L, Yang G, Tang G, Wu L, and Wang R. Rat pancreatic level of cystathionine c-lyase is regulated by glucose level via specificity protein 1 (SP1) phosphorylation. Diabetologia 54: 2615-2625, 2011.